Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FPRX

Five Prime Therapeutics (FPRX) Stock Price, News & Analysis

Five Prime Therapeutics logo

About Five Prime Therapeutics Stock (NASDAQ:FPRX)

Advanced Chart

Key Stats

Today's Range
$38.00
$38.00
50-Day Range
$37.65
$38.00
52-Week Range
$2.61
$38.90
Volume
N/A
Average Volume
1.98 million shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Five Prime Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

FPRX Stock News Headlines

A new rule goes live in July — and the banks are quietly cashing in
A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.
CMMB Chemomab Therapeutics Ltd.
What Is The Prime Rate Today?
See More Headlines

FPRX Stock Analysis - Frequently Asked Questions

Five Prime Therapeutics, Inc. (NASDAQ:FPRX) posted its earnings results on Friday, November, 6th. The biotechnology company reported ($0.74) EPS for the quarter, missing the consensus estimate of ($0.60) by $0.14. The biotechnology company had revenue of $2.05 million for the quarter, compared to analysts' expectations of $3.50 million. Five Prime Therapeutics had a negative trailing twelve-month return on equity of 75.84% and a negative net margin of 554.71%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Five Prime Therapeutics investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), OPKO Health (OPK), Pfizer (PFE), Nektar Therapeutics (NKTR), Advanced Micro Devices (AMD) and Inovio Pharmaceuticals (INO).

Company Calendar

Last Earnings
11/06/2020
Today
7/02/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FPRX
Fax
N/A
Employees
87
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$137.20 million
Net Margins
-554.71%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$14.87 million
Price / Cash Flow
N/A
Book Value
$4.13 per share
Price / Book
9.20

Miscellaneous

Free Float
N/A
Market Cap
$1.77 billion
Optionable
Optionable
Beta
4.40
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:FPRX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners